vs
Limbach Holdings, Inc.（LMB）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Limbach Holdings, Inc.的1.2倍（$219.9M vs $186.9M），Limbach Holdings, Inc.净利率更高（6.6% vs -1.0%，领先7.6%），Limbach Holdings, Inc.同比增速更快（30.1% vs 2.0%），Limbach Holdings, Inc.自由现金流更多（$27.9M vs $16.8M），过去两年Limbach Holdings, Inc.的营收复合增速更高（25.3% vs 8.0%）
林巴赫航空发动机是一家由中资控股、总部位于德国的企业，主营航空发动机的研发与制造业务，在航空动力装备领域拥有成熟的生产技术与行业经验。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
LMB vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.2倍
$186.9M
营收增速更快
LMB
高出28.1%
2.0%
净利率更高
LMB
高出7.6%
-1.0%
自由现金流更多
LMB
多$11.1M
$16.8M
两年增速更快
LMB
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $186.9M | $219.9M |
| 净利润 | $12.3M | $-2.2M |
| 毛利率 | 25.7% | 71.1% |
| 营业利润率 | 9.4% | 0.2% |
| 净利率 | 6.6% | -1.0% |
| 营收同比 | 30.1% | 2.0% |
| 净利润同比 | 25.0% | 92.4% |
| 每股收益（稀释后） | $1.01 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LMBOFIX
| Q4 25 | $186.9M | $219.9M | ||
| Q3 25 | $184.6M | $205.6M | ||
| Q2 25 | $142.2M | $203.1M | ||
| Q1 25 | $133.1M | $193.6M | ||
| Q4 24 | $143.7M | $215.7M | ||
| Q3 24 | $133.9M | $196.6M | ||
| Q2 24 | $122.2M | $198.6M | ||
| Q1 24 | $119.0M | $188.6M |
净利润LMBOFIX
| Q4 25 | $12.3M | $-2.2M | ||
| Q3 25 | $8.8M | $-22.8M | ||
| Q2 25 | $7.8M | $-14.1M | ||
| Q1 25 | $10.2M | $-53.1M | ||
| Q4 24 | $9.8M | $-29.1M | ||
| Q3 24 | $7.5M | $-27.4M | ||
| Q2 24 | $6.0M | $-33.4M | ||
| Q1 24 | $7.6M | $-36.0M |
毛利率LMBOFIX
| Q4 25 | 25.7% | 71.1% | ||
| Q3 25 | 24.2% | 72.2% | ||
| Q2 25 | 28.0% | 68.7% | ||
| Q1 25 | 27.6% | 62.8% | ||
| Q4 24 | 30.3% | 69.0% | ||
| Q3 24 | 27.0% | 68.7% | ||
| Q2 24 | 27.4% | 67.8% | ||
| Q1 24 | 26.1% | 67.5% |
营业利润率LMBOFIX
| Q4 25 | 9.4% | 0.2% | ||
| Q3 25 | 7.2% | -8.3% | ||
| Q2 25 | 7.5% | -7.9% | ||
| Q1 25 | 5.9% | -25.2% | ||
| Q4 24 | 9.1% | -5.3% | ||
| Q3 24 | 8.1% | -9.6% | ||
| Q2 24 | 6.7% | -12.5% | ||
| Q1 24 | 5.5% | -15.6% |
净利率LMBOFIX
| Q4 25 | 6.6% | -1.0% | ||
| Q3 25 | 4.8% | -11.1% | ||
| Q2 25 | 5.5% | -6.9% | ||
| Q1 25 | 7.7% | -27.4% | ||
| Q4 24 | 6.9% | -13.5% | ||
| Q3 24 | 5.6% | -13.9% | ||
| Q2 24 | 4.9% | -16.8% | ||
| Q1 24 | 6.4% | -19.1% |
每股收益（稀释后）LMBOFIX
| Q4 25 | $1.01 | $-0.05 | ||
| Q3 25 | $0.73 | $-0.57 | ||
| Q2 25 | $0.64 | $-0.36 | ||
| Q1 25 | $0.85 | $-1.35 | ||
| Q4 24 | $0.81 | $-0.76 | ||
| Q3 24 | $0.62 | $-0.71 | ||
| Q2 24 | $0.50 | $-0.88 | ||
| Q1 24 | $0.64 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.3M | $82.0M |
| 总债务越低越好 | $30.5M | — |
| 股东权益账面价值 | $195.7M | $450.0M |
| 总资产 | $381.1M | $850.6M |
| 负债/权益比越低杠杆越低 | 0.16× | — |
8季度趋势，按日历期对齐
现金及短期投资LMBOFIX
| Q4 25 | $11.3M | $82.0M | ||
| Q3 25 | $9.8M | $62.9M | ||
| Q2 25 | $38.9M | $65.6M | ||
| Q1 25 | $38.1M | $58.0M | ||
| Q4 24 | $44.9M | $83.2M | ||
| Q3 24 | $51.2M | $30.1M | ||
| Q2 24 | $59.5M | $26.4M | ||
| Q1 24 | $48.2M | $27.0M |
总债务LMBOFIX
| Q4 25 | $30.5M | — | ||
| Q3 25 | $56.3M | $157.2M | ||
| Q2 25 | $28.4M | $157.0M | ||
| Q1 25 | $23.7M | $156.9M | ||
| Q4 24 | $23.6M | $157.0M | ||
| Q3 24 | $20.5M | $118.5M | ||
| Q2 24 | $19.7M | $118.0M | ||
| Q1 24 | $19.4M | $118.2M |
股东权益LMBOFIX
| Q4 25 | $195.7M | $450.0M | ||
| Q3 25 | $181.6M | $442.5M | ||
| Q2 25 | $170.5M | $458.3M | ||
| Q1 25 | $161.1M | $458.3M | ||
| Q4 24 | $153.5M | $503.1M | ||
| Q3 24 | $142.2M | $525.9M | ||
| Q2 24 | $133.0M | $546.0M | ||
| Q1 24 | $125.5M | $570.3M |
总资产LMBOFIX
| Q4 25 | $381.1M | $850.6M | ||
| Q3 25 | $409.1M | $832.6M | ||
| Q2 25 | $343.0M | $837.2M | ||
| Q1 25 | $336.4M | $823.1M | ||
| Q4 24 | $352.1M | $893.3M | ||
| Q3 24 | $324.4M | $867.9M | ||
| Q2 24 | $303.9M | $882.0M | ||
| Q1 24 | $289.2M | $906.0M |
负债/权益比LMBOFIX
| Q4 25 | 0.16× | — | ||
| Q3 25 | 0.31× | 0.36× | ||
| Q2 25 | 0.17× | 0.34× | ||
| Q1 25 | 0.15× | 0.34× | ||
| Q4 24 | 0.15× | 0.31× | ||
| Q3 24 | 0.14× | 0.23× | ||
| Q2 24 | 0.15× | 0.22× | ||
| Q1 24 | 0.15× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.1M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $27.9M | $16.8M |
| 自由现金流率自由现金流/营收 | 14.9% | 7.6% |
| 资本支出强度资本支出/营收 | 0.1% | 4.9% |
| 现金转化率经营现金流/净利润 | 2.29× | — |
| 过去12个月自由现金流最近4个季度 | $41.9M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流LMBOFIX
| Q4 25 | $28.1M | $27.7M | ||
| Q3 25 | $13.3M | $12.4M | ||
| Q2 25 | $2.0M | $11.6M | ||
| Q1 25 | $2.2M | $-18.4M | ||
| Q4 24 | $19.3M | $23.7M | ||
| Q3 24 | $4.9M | $11.7M | ||
| Q2 24 | $16.5M | $9.0M | ||
| Q1 24 | $-3.9M | $-18.6M |
自由现金流LMBOFIX
| Q4 25 | $27.9M | $16.8M | ||
| Q3 25 | $12.8M | $2.5M | ||
| Q2 25 | $1.2M | $4.5M | ||
| Q1 25 | $11.0K | $-25.1M | ||
| Q4 24 | $18.0M | $15.2M | ||
| Q3 24 | $4.6M | $6.3M | ||
| Q2 24 | $13.2M | $-360.0K | ||
| Q1 24 | $-6.5M | $-29.1M |
自由现金流率LMBOFIX
| Q4 25 | 14.9% | 7.6% | ||
| Q3 25 | 7.0% | 1.2% | ||
| Q2 25 | 0.8% | 2.2% | ||
| Q1 25 | 0.0% | -13.0% | ||
| Q4 24 | 12.5% | 7.0% | ||
| Q3 24 | 3.4% | 3.2% | ||
| Q2 24 | 10.8% | -0.2% | ||
| Q1 24 | -5.5% | -15.4% |
资本支出强度LMBOFIX
| Q4 25 | 0.1% | 4.9% | ||
| Q3 25 | 0.3% | 4.8% | ||
| Q2 25 | 0.6% | 3.5% | ||
| Q1 25 | 1.7% | 3.5% | ||
| Q4 24 | 0.9% | 4.0% | ||
| Q3 24 | 0.3% | 2.7% | ||
| Q2 24 | 2.7% | 4.7% | ||
| Q1 24 | 2.1% | 5.6% |
现金转化率LMBOFIX
| Q4 25 | 2.29× | — | ||
| Q3 25 | 1.52× | — | ||
| Q2 25 | 0.26× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 1.96× | — | ||
| Q3 24 | 0.66× | — | ||
| Q2 24 | 2.77× | — | ||
| Q1 24 | -0.52× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LMB
| Owner Direct Relationships Segment | $145.0M | 78% |
| General Contractor Construction Manager Relationships Segment | $41.9M | 22% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
